Wei-Fan Hsu

17PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceMedical biochemistry - lipidsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 20, 2026
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B.

|Oct 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication.

Wei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng

|Jun 26, 2025
Editorial: Beyond Viral Eradication-Scrutinising Outcomes After Hepatitis C Cure.

Wei-Fan Hsu, Cheng-Yuan Peng

|May 12, 2025
Key Role of Recompensation in Systemic Therapy for Hepatocellular Carcinoma.

Patrick Twohig, Wei-Fan Hsu, Nida Ansari

|Dec 16, 2024
Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B.

Wei-Fan Hsu, Chuen-Fei Chen, Hsueh-Chou Lai

|Nov 18, 2024
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma.

Hung-Wei Wang, Hsueh-Chou Lai, Wen-Pang Su

Pageof 3

Frequent Collaborators

9 joint publications

Cheng-Yuan Peng

5 joint publications

Hung-Wei Wang

3 joint publications

Yi-Hsiang Huang

2 joint publications

Jia-Horng Kao